Literature DB >> 15243106

Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.

Parissa Farnia1, Foroazan Mohammadi, Mehdi Mirsaedi, Abolhasan Zia Zarife, Javad Tabatabee, Katayoon Bahadori, Muslem Bahadori, Mohammad Reza Masjedi, Ali Akbar Velayati.   

Abstract

By oxidation-reduction assay, the viability of Mycobacterium tuberculosis in sputum specimens was evaluated. The technique is based on the Alamar Blue and Malachite Green dyes, which change their color in response to M. tuberculosis growth. The method is simple, permits visual reading of results, and is applicable for laboratories with limited resources.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15243106      PMCID： PMC446278          DOI： 10.1128/JCM.42.7.3324-3325.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.

Authors:  H Ramarokoto; H Randriamiharisoa; A Rakotoarisaonina; T Rasolovavalona; V Rasolofo; S Chanteau; M Ralamboson; B Cauchoix; D Rakotondramarina
Journal:  Int J Tuberc Lung Dis       Date:  2002-10       Impact factor: 2.373

2.  Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes.

Authors:  Somnuek Sungkanuparph; Roongnapa Pracharktam; Ammarin Thakkinstian; Benjamas Buabut; Wiphawee Kiatatchasai
Journal:  J Med Assoc Thai       Date:  2002-07

3.  Sputum microscopy results at two and three months predict outcome of tuberculosis treatment.

Authors:  F Z Zhao; M H Levy; S Wen
Journal:  Int J Tuberc Lung Dis       Date:  1997-12       Impact factor: 2.373

4.  Sputum smear conversion during directly observed treatment for tuberculosis.

Authors:  H L Rieder
Journal:  Tuber Lung Dis       Date:  1996-04

5.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV.

Authors:  K M De Cock; D Wilkinson
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

7.  Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment.

Authors:  R Vidal; N Martin-Casabona; A Juan; T Falgueras; M Miravitlles
Journal:  Chest       Date:  1996-06       Impact factor: 9.410

8.  Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.

Authors:  J B Bass; L S Farer; P C Hopewell; R O'Brien; R F Jacobs; F Ruben; D E Snider; G Thornton
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

9.  Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis.

Authors:  T J Hellyer; L E DesJardin; G L Hehman; M D Cave; K D Eisenach
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.

Authors:  D M Yajko; J J Madej; M V Lancaster; C A Sanders; V L Cawthon; B Gee; A Babst; W K Hadley
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948
View more
  5 in total

1.  Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye.

Authors:  Parissa Farnia; Mohammad Reza Masjedi; Foroozan Mohammadi; Payam Tabarsei; Poopak Farnia; Ali Reza Mohammadzadeh; Parvaneh Baghei; Mohammad Varahram; Sven Hoffner; Ali Akbar Velayati
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

2.  Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.

Authors:  Dalin Rifat; Si-Yang Li; Thomas Ioerger; Keshav Shah; Jean-Philippe Lanoix; Jin Lee; Ghader Bashiri; James Sacchettini; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 3.  Diagnosis & treatment of tuberculosis in HIV co-infected patients.

Authors:  C Padmapriyadarsini; G Narendran; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

4.  The Bandim TBscore--reliability, further development, and evaluation of potential uses.

Authors:  Frauke Rudolf
Journal:  Glob Health Action       Date:  2014-05-22       Impact factor: 2.640

Review 5.  Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.

Authors:  Narendran Gopalan; Padmapriyadarsini Chandrasekaran; Soumya Swaminathan; Srikanth Tripathy
Journal:  AIDS Res Ther       Date:  2016-09-26       Impact factor: 2.250
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.